Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.52B |
| 2 |
NVIDIA
NVDA
|
+$732M |
| 3 |
ProShares UltraPro QQQ
TQQQ
|
+$555M |
| 4 |
Dell
DELL
|
+$542M |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.18B |
| 2 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$1.29B |
| 3 |
Visa
V
|
+$1.12B |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$918M |
| 5 |
Broadcom
AVGO
|
+$892M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.93% |
| 2 | Consumer Discretionary | 1.52% |
| 3 | Healthcare | 0.84% |
| 4 | Financials | 0.83% |
| 5 | Communication Services | 0.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
8201
T. Rowe Price International Equity ETF
TOUS
$1.64B
| $261K | ﹤0.01% |
8,962
-25,030
| -74% | -$702K |
|
8202
PUT
Caleres
CAL
$486M
| $261K | ﹤0.01% |
7,900
-13,400
| -63% | -$486K |
|
8203
CALL
Perimeter Solutions
PRM
$5.65B
| $261K | ﹤0.01% |
19,400
-700
| -3% | -$7.25K |
|
8204
JFrog
FROG
$10.7B
| $261K | ﹤0.01% |
8,976
-86,713
| -91% | -$2.72M |
|
8205
Victory Portfolios II VictoryShares Corporate Bond ETF
UCRD
$148M
| $260K | ﹤0.01% |
11,887
-28,923
| -71% | -$622K |
|
8206
MaxCyte
MXCT
$130M
| $260K | ﹤0.01% |
66,868
-50,716
| -43% | -$214K |
|
8207
ALPS International Sector Dividend Dogs ETF
IDOG
$563M
| $260K | ﹤0.01% |
+8,153
| New | +$251K |
|
8208
iShares ESG Aware Conservative Allocation ETF
EAOK
$8.45M
| $259K | ﹤0.01% |
+9,799
| New | +$253K |
|
8209
PUT
Coeur Mining
CDE
$18.7B
| $259K | ﹤0.01% |
37,700
-7,000
| -16% | -$43.6K |
|
8210
Fidelity Sustainable High Yield ETF
FSYD
$145M
| $259K | ﹤0.01% |
5,371
-2,749
| -34% | -$131K |
|
8211
Invesco Investment Grade Defensive ETF
IIGD
$26.8M
| $259K | ﹤0.01% |
10,473
-45,272
| -81% | -$1.11M |
|
8212
CALL
Cardlytics
CDLX
$22.4M
| $259K | ﹤0.01% |
8,100
-7,870
| -49% | -$437K |
|
|
OPTU
8213
PUT
Optimum Communications Inc
OPTU
$306M
| $259K | ﹤0.01% |
105,300
-300
| -0.3% | -$579 |
|
8214
State Street SPDR S&P Pharmaceuticals ETF
XPH
$512M
| $259K | ﹤0.01% |
5,839
-52,269
| -90% | -$2.24M |
|
|
INZY
8215
DELISTED
Inozyme Pharma
INZY
| $259K | ﹤0.01% |
49,460
+3,443
| +7% | +$17.9K |
|
8216
Invesco Dorsey Wright Technology Momentum ETF
PTF
$620M
| $259K | ﹤0.01% |
+4,078
| New | +$248K |
|
8217
Redwire
RDW
$3.28B
| $259K | ﹤0.01% |
37,642
+9,081
| +32% | +$60K |
|
8218
CALL
Ramaco Resources Class A
METC
$645M
| $259K | ﹤0.01% |
22,842
+3,824
| +20% | +$45.6K |
|
8219
PUT
O-I Glass
OI
$1.08B
| $258K | ﹤0.01% |
+19,700
| New | +$236K |
|
8220
Western Midstream Partners
WES
$19.6B
| $258K | ﹤0.01% |
6,748
-291,893
| -98% | -$11.5M |
|
8221
CALL
Tilray
TLRY
$602M
| $258K | ﹤0.01% |
14,660
+4,450
| +44% | +$80.1K |
|
8222
First Trust Nasdaq Food & Beverage ETF
FTXG
$18.2M
| $258K | ﹤0.01% |
+10,061
| New | +$249K |
|
8223
Getty Images
GETY
$186M
| $258K | ﹤0.01% |
67,712
+39,477
| +140% | +$139K |
|
8224
Arbutus Biopharma
ABUS
$907M
| $258K | ﹤0.01% |
66,910
-136,488
| -67% | -$524K |
|
|
EFXT
8225
Enerflex
EFXT
$2.5B
| $257K | ﹤0.01% |
43,179
-184,899
| -81% | -$1.04M |
|
Similar funds
Jane Street's Q3 2024 Portfolio in Review
As of Q3 2024, Jane Street held 10,828 positions worth $453B, up 3.6% from $438B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Jane Street withdrew a net $18.5B in Q3 2024, closing 1,349 positions and reducing 4,327 holdings. Its most notable exit was iShares Core MSCI International Developed Markets ETF, an estimated $290M position sold in full.
By sector, the portfolio is most concentrated in Technology at 2.9% of assets, down from 4.6% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jane Street opened a new position in Schwab Short-Term US Treasury ETF worth $424M.
- Jane Street's largest Q3 2024 buy was Schwab Short-Term US Treasury ETF: 17,304,274 shares worth $424M.
- Jane Street added most to State Street SPDR S&P 500 ETF Trust in Q3 2024, an estimated $2.52B increase.
- Jane Street's biggest Q3 2024 reduction was Apple, cutting an estimated $4.18B.
- Jane Street fully exited iShares Core MSCI International Developed Markets ETF in Q3 2024, selling an estimated $290M.
- Jane Street's ten largest holdings make up 44% of its $453B portfolio in Q3 2024.
- Jane Street opened 1,593 new positions and closed 1,349 in Q3 2024.
- Jane Street's portfolio value rose 3.6% quarter-over-quarter to $453B.
Based on Jane Street's 13F filing for Q3 2024, filed 15 Nov 2024.